Samarendra Mohanty | President and Chief Scientific Officer
Nanoscope Therapeutics

Samarendra Mohanty, President and Chief Scientific Officer, Nanoscope Therapeutics

Dedicated to transforming scientific discoveries into life-changing therapies, Dr. Samarendra Mohanty co-founded Nanoscope Therapeutics and serves as president and chief scientific officer. With over 25 years of experience in biomedical sciences, Dr. Mohanty has co-founded several biotech and medical device companies focused on developing and commercializing innovative diagnostics and therapeutic technologies. His mission-driven work bridges cutting-edge science and patient impact, with a focus on neurological and ophthalmic disorders. Dr. Mohanty holds an M.Tech in Applied Optics from IIT Delhi and a PhD in (Bio)Physics from IISc Bangalore. He has held senior academic and research positions worldwide and is Principal Investigator for major NIH-funded projects. With over 200 international patents and publications in top journals like Nature, Dr. Mohanty remains a leader in biomedical innovation. He continues to innovate and serve on the Boards of many biotech companies.

Appearances:



Advanced Therapies USA 2025 - Day 1 @ 09:05

Keynote Panel Discussion: State of the Industry Address for Cell and Gene Therapies

Advanced Therapies USA 2025 - Day 1 @ 15:15

Mutation agnostic gene therapy for neurodegenerative diseases

last published: 10/Jul/25 18:55 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604